The GTPase-activating protein RasGAP functions as both a negative regulator and an effector of Ras proteins. In tumor cells, RasGAP is no longer able to deactivate oncogenic Ras proteins, and its effector function becomes predominant. As RasGAP itself has no obvious enzymatic function that may explain this effector function, we looked for downstream RasGAP effectors that could fulfill this role. We looked for the existence of RasGAP Src homology 3 (SH3) domain partners as this domain is involved in the regulation of cell proliferation and has an anti-apoptotic effect. We report here the identification of a new RasGAP SH3 domain-binding protein, named Aurora. This Drosophila melanogaster Ser/Thr kinase has three human orthologs called Aurora/Ipl1-related kinase or HsAIRK-1, -2, and -3. Coimmunoprecipitation experiments in COS cells confirmed that HsAIRK-1 and HsAIRK-2 both interact with Ras-GAP. RasGAP pull-down experiments showed that it interacts with HsAIRK-1 in G 2 /M HeLa cells. We also demonstrated that RasGAP binds to the kinase domain of Aurora and that this interaction inhibits the kinase activity of HsAIRK-1 and HsAIRK-2. Finally we showed that RasGAP forms a ternary complex with HsAIRK and survivin. This complex may be involved in the regulation of the balance between cell division and apoptosis.
The GTPase-activating protein RasGAP functions as both a negative regulator and an effector of Ras proteins. In tumor cells, RasGAP is no longer able to deactivate oncogenic Ras proteins, and its effector function becomes predominant. As RasGAP itself has no obvious enzymatic function that may explain this effector function, we looked for downstream RasGAP effectors that could fulfill this role. We looked for the existence of RasGAP Src homology 3 (SH3) domain partners as this domain is involved in the regulation of cell proliferation and has an anti-apoptotic effect. We report here the identification of a new RasGAP SH3 domain-binding protein, named Aurora. This Drosophila melanogaster Ser/Thr kinase has three human orthologs called Aurora/Ipl1-related kinase or HsAIRK-1, -2, and -3. Coimmunoprecipitation experiments in COS cells confirmed that HsAIRK-1 and HsAIRK-2 both interact with Ras-GAP. RasGAP pull-down experiments showed that it interacts with HsAIRK-1 in G 2 /M HeLa cells. We also demonstrated that RasGAP binds to the kinase domain of Aurora and that this interaction inhibits the kinase activity of HsAIRK-1 and HsAIRK-2. Finally we showed that RasGAP forms a ternary complex with HsAIRK and survivin. This complex may be involved in the regulation of the balance between cell division and apoptosis.
Ras proteins play a key role in the control of proliferation and differentiation (1) . The function of Ras in mammalian cells depends upon the activities of guanine exchange factors, which catalyze the exchange of GDP/GTP (2) , and the activities of GTPase-activating proteins (GAPs) 1 such as RasGAP and neurofibromin (3) . RasGAP was first identified as a cytosolic protein able to stimulate the GTP hydrolysis of GTP bound to p21 ras (4) and is thus essentially described as a negative regulator of Ras. In the case of cells expressing oncogenic forms of Ras, RasGAP is no longer able to deactivate Ras. However, in these cells, RasGAP acts as a Ras effector, displaying functions associated with proliferation, differentiation, and apoptosis independently of its GAP activity (5) . These effects may be transduced by unknown RasGAP partners. RasGAP displays its GAP activity via its COOH-terminal domain (6) . Its NH 2 -terminal region appears to be essential to trigger downstream signals (7, 8) . Interestingly the NH 2 -terminal region contains several domains involved in interactions with different proteins in vitro, notably an SH3 domain flanked by two SH2 domains. These SH2 domains can associate with phosphorylated tyrosine kinase receptors (platelet-derived growth factor and epidermal growth factor), v-Src, and two phosphotyrosine-containing proteins, p62 and p190 RhoGAP (9 -11) .
SH3 domains are about 60 amino acids long and mediate interactions with proline-containing motifs within their partners (12) . The RasGAP SH3 domain is unusual as no prolinerich sequences able to bind this SH3 domain have been found. Several studies have shown that the RasGAP SH3 domain is important in oncogenic Ras signaling pathways (13) (14) (15) (16) . In fact, the microinjection of a monoclonal antibody directed against the RasGAP SH3 domain specifically induces cell death by apoptosis in tumor cells but not in normal cells (13) . The RasGAP SH3 domain is also involved in cytoskeletal reorganization, cell adhesion, and the induction of gene expression in a Ras-dependent manner (14 -16) . RasGAP associates with the GAP SH3-binding protein and an unknown 14-kDa protein through its SH3 domain (17, 18) . However, the RNase GAP SH3-binding protein was not related to the known roles of RasGAP in the previous effects (19, 20) .
Our aim was to identify proteins that interact with the RasGAP SH3 domain to further improve our understanding of its role in cell division and apoptosis. We used a two-hybrid approach to identify one such a protein, which was shown to be the Ser/Thr kinase Aurora. Finally we showed that RasGAP and Aurora form a ternary complex with the survivin protein in vivo.
EXPERIMENTAL PROCEDURES
Antibodies-A rabbit polyclonal antibody (pAb) and a mouse monoclonal antibody (mAb) directed against the RasGAP COOH-terminal SH2 domain (G12930 and G12920, respectively) were purchased from Transduction Laboratories. The mouse mAb directed against FLAG (M2) and the pAb directed against survivin (FL-142) were purchased from Sigma and Santa Cruz Biotechnology, respectively. The rabbit immune serum directed against HsAIRK-1 was a gift from Aventis Pharma.
DNA Constructs-DNA sequences corresponding to the SH3 domain of human RasGAP (Hs GAP SH3, residues 275-342), the SH3 domain of Drosophila melanogaster RasGAP (Dm GAP SH3, residues 176 -252), and the SH2-SH3-SH2 region of human RasGAP (GAP SH2-3-2, residues 170 -440) were amplified by PCR and cloned in-frame with the GAL4 DNA-binding domain (GAL4BD) in pGBT10. Human RasGAP cDNA was a gift from Aventis Pharma. For expression in mammalian cells, the cDNAs encoding HsAIRK-1 and HsAIRK-2 were amplified by PCR, and the products were inserted in-frame with the NH 2 -terminal FLAG and COOH-terminal Myc tags in p3X-FLAG-Myc-CMV-24 (referred to as p3XFLAG vector hereafter, Sigma).
Site-directed Mutagenesis-Site-directed mutagenesis was carried out using the QuikChange TM site-directed mutagenesis kit (Stratagene) according to the manufacturer's instructions. A mutation (W317K) was introduced into the pGAL4BD-Hs GAP SH3 vector using oligonucleotides based on the published human RasGAP cDNA sequence. The mutation was confirmed by sequencing on an automated sequencer (Applied Biosystems).
Yeast Two-hybrid Screening-Yeast two-hybrid procedures were carried out using a mating approach with HF7 and Y187 yeast strains (21) . The SH3 domain of the D. melanogaster RasGAP was fused in-frame with the GAL4 DNA-binding domain (pGAL4BD-Dm GAP SH3) and used as the bait to screen an oligo(dT)-primed D. melanogaster 0 -24-h embryo cDNA library cloned in pACTII (a gift from S. Elledge). Plasmids from positive clones were rescued, and their specificity was tested with Dm GAP SH3, Hs GAP SH3, GAP SH2-3-2, Hs GAP SH3 mutant (W317K), human Grb2, and human Nck baits containing irrelevant SH3 domains.
Cell Culture and Transient Expression in COS Cells-COS cells (1.5 ϫ 10 6 ) were plated onto culture dishes (100-mm diameter) and grown overnight in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS) and 100 units/ml penicillin/ streptomycin in a 5% CO 2 atmosphere at 37°C. The DEAE-dextran method was then used to transfect cells with 1 g of p3XFLAG vector with or without the cDNA encoding HsAIRK-1 (GenBank TM accession numbers GI:4507278) or HsAIRK-2 (GI:4759177). After transfection, cells were grown for 48 h before being lysed with the appropriate buffer for further analysis.
Cell Culture and Cell Cycle Synchronization of HeLa CellsExponential phase HeLa cells were cultured in DMEM with 10% FCS. For G 1 /S synchronization, cells were treated with 2.5 mM thymidine for 18 -24 h, released for 8 -10 h, and then treated with thymidine for 16 -18 h. For G 2 /M synchronization, cells were submit to double-block thymidine, released for 6 -8 h with DMEM, 10% FCS, and finally incubated in the presence of 400 ng/ml nocodazole (Sigma) for 16 -18 h.
Immunoprecipitations and Immunoblotting-Cells were washed four times with ice-cold phosphate-buffered saline. Cells were lysed in 250 l of lysis buffer consisting of 50 mM HEPES, pH 7.5, 150 mM NaCl, 1% Triton X-100, 10% glycerol, 1 mM MgCl 2 , 1 mM EGTA, phosphatase inhibitor (1 mM Na 3 VO 4 ), kinase inhibitor (10 mM NaF), and protease inhibitors (1 mM phenylmethylsulfonyl fluoride and Complete TM protease inhibitors mixture, Roche Molecular Biochemicals). After a 15-min incubation at 4°C, the lysate was collected, solubilized for 30 min at 4°C with gentle rocking, and centrifuged at 13,000 ϫ g for 10 min at 4°C to remove insoluble material. The protein concentration was determined by the Bradford method (Sigma). Proteins of interest were immunoprecipitated with the corresponding antibodies coupled to either protein G-or protein A-Sepharose for 2 h at 4°C with gentle rocking. The immune complexes were collected by centrifugation, washed four times with HNT buffer containing 50 mM HEPES, 150 mM NaCl, 0.1% Triton X-100, pH 7.5, and solubilized in 25 l of sample buffer. Proteins were then separated by SDS-PAGE and electroblotted onto nitrocellulose membranes. The membranes were incubated overnight at 4°C in Superblock buffer (Pierce) and blotted for 1 h at room temperature with the corresponding primary antibodies: mAb GAP SH2 (1:1000), anti-FLAG (1 g/ml) antibody, or anti-survivin (1:500) antibody. After secondary antibody (peroxidase-conjugated anti-rabbit or anti-mouse IgG, Amersham Biosciences) incubation for 30 min at room temperature, immunoreactive bands were detected by use of the ECL immunodetection system (Amersham Biosciences).
RasGAP Pull-down Assay-Cell lysates were prepared as previously described for the immunoprecipitation experiments. RasGAP was precipitated by use of the PALpYAEPLDSL (where pY is phosphotyrosine) peptide coupled to CNBr-activated Sepharose beads. This peptide is derived from the p62 dok protein and binds to the RasGAP NH 2 -terminal SH2 domain. Proteins were separated by SDS-PAGE and electroblotted onto nitrocellulose membrane. Western blotting was performed as previously described using the following primary antibodies: mAb GAP SH2 (1:1000) and anti-HsAIRK-1 serum (1:10,000).
Protein Kinase Assay-Assays were performed in 100 l of 50 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM dithiothreitol, 10 mM MgCl 2 , 10 M
ATP containing 10 Ci of [␥-
32 P]ATP at 5,000 Ci/mmol (Amersham Biosciences), and 10 g of myelin basic protein (Sigma). After 10 min at 30°C with shaking, 25 l of the sample was withdrawn and placed on a piece of p81 Whatman paper (0.5 ϫ 1.5 cm). The paper was washed three times with 5% orthophosphoric acid (2 ml/sample), and the radioactivity was counted. The results are expressed as the means of three to five independent transfection experiments and normalized according to the optical density of the immunoprecipitated proteins from the Western blotting experiments.
RESULTS
Yeast Two-hybrid Screening for RasGAP SH3 Domain Partners-The yeast two-hybrid system was used to identify proteins that interact with the RasGAP SH3 domain. cDNA corresponding to amino acids 176 -252 of the D. melanogaster RasGAP (Dm GAP SH3) was fused to the GAL4BD and used as the bait to screen a two-hybrid D. melanogaster embryonic cDNA library. We obtained 6 ϫ 10 6 transformants including 150 His
To analyze the specificity of their interactions, the 150 plasmids were isolated, retransformed into yeast Y187, and mated with the HF7 strain expressing either the GAL4BD alone or fused to Hs GAP SH3, Dm GAP SH3, GAP SH2-3-2 (containing the Hs GAP SH3 domain flanked with the two SH2 domains), the Hs GAP SH3 mutant (W317K), human Grb2, and human Nck (Fig. 1) . This led to the identification of two preys that 1) allowed robust growth on histidine-free plates and displayed strong ␤-galactosidase activity when co-expressed with baits containing the wild-type GAP SH3 domain, 2) yielded no growth in the presence of Grb2 or Nck, which contain two and three SH3 domains, respectively, and 3) produced no growth in the presence of RasGAP SH3 W317K, which carries a mutation in a position known to disrupt SH3 domain interactions (Fig. 1) thologs, HsAIRK-1 and HsAIRK-2, are ubiquitously expressed proteins, whereas HsAIRK-3 is expressed only in the testis (22) . Our two-hybrid assay confirmed that HsAIRK-1 and HsAIRK-2 orthologs interact with the Dm GAP SH3 domain (Fig. 1A) . The same results were obtained with the Hs GAP SH3 domain (data not shown). For in vivo studies, HsAIRK-1 and HsAIRK-2 were cloned into the p3XFLAG vector and expressed in COS cells. The in vivo interactions between RasGAP and HsAIRK-1 or HsAIRK-2 were studied by immunoprecipitation experiments performed on transfected COS cell lysates (Fig. 2) . When endogenous RasGAP was immunoprecipitated in lysates from p3XFLAG-HsAIRK-1-or p3XFLAG-HsAIRK-2-transfected COS cells, RasGAP and the kinases were co-precipitated.
RasGAP Interacts with the Aurora Kinase Domain and Inhibits HsAIRK Activity-Two truncated versions of Aurora were generated in an attempt to locate the region involved in the binding of Aurora to the RasGAP SH3 domain (Fig. 3A) . The NH 2 -terminal (residues 1-152) and the COOH-terminal (residues 153-411) domains were cloned independently into the pACTII vector, and mating experiments were carried out to determine whether these domains interacted with the RasGAP SH3 domain. The RasGAP SH3 domain bound to the COOHterminal domain of Aurora but not to the NH 2 -terminal domain (Fig. 3B) . These results are consistent with the conserved interaction between RasGAP and the Aurora/HsAIRKs proteins and with the fact that the COOH-terminal kinase domain is highly preserved throughout evolution (identity/similarity 58/ 68% between Aurora and HsAIRK-1). Interestingly this minimal interaction domain does not contain any proline-rich consensus sequences. This is in accordance with 1) the lack of a recognition platform required for the preferential binding to a proline-rich consensus sequence in the RasGAP SH3 domain and 2) the fact that no consensus proline-rich motif has been shown to bind to the RasGAP SH3 domain (23) .
We investigated whether RasGAP modulated the kinase activity of HsAIRK proteins. The p3XFLAG-HsAIRK-1 and p3XFLAG-HsAIRK-2 were expressed in COS cells, and the kinase activity was measured after immunoprecipitation using anti-FLAG or anti-RasGAP antibodies (Fig. 3C) . Results are normalized with optical density of immunoprecipitated proteins from the Western blot. When expressed in the p3XFLAG vector, HsAIRK-1 and HsAIRK-2 were highly expressed and active, whereas they were inactive when they were co-immunoprecipitated with the anti-RasGAP antibody. These results suggest that the kinase activity of HsAIRK proteins is inhibited by bound RasGAP.
RasGAP Forms a Complex with HsAIRK and Survivin in G 2 /M HeLa Cells-HsAIRK proteins are mainly expressed at the G 2 /M transition and during mitosis (22) . In fact, we confirmed that HsAIRK-1 is highly expressed at G 2 /M transition The COOH-terminal region contains the catalytic domain that increases GTPase activity of Ras. The NH 2 -terminal region consists of a proline-rich domain, two SH2 domains, one SH3 domain, a pleckstrin homology (PH) domain, and a calcium-dependent phospholipid-binding domain (CalB). The Aurora/HsAIRK proteins consist of two regions: a divergent NH 2 -terminal region and a conserved COOH-terminal domain with Ser/Thr kinase activity. B, Y187 yeast strains expressing truncated preys encoding the NH 2 -terminal or the COOH-terminal domain of Aurora were mated with the HF7 strain expressing the Dm GAP SH3 domain. C, RasGAP inhibits the kinase activity of Aurora. COS cells transfected with the p3XFLAG vector alone (lanes Ϫ) or fused to HsAIRK-1/HsAIRK-2 (lanes ϩ) were submitted to immunoprecipitation using anti-RasGAP or anti-FLAG antibodies followed by kinase assays. The Cϩ lane is used as a positive control corresponding to total cellular extracts submitted to kinase assay. Results are the means of three to five independent transfection experiments and normalized with optical density of immunoprecipitated proteins from the Western blot. FLAG-immunoprecipitated HsAIRK-1 and HsAIRK-2 contained significant kinase activity with the exception of those that immunoprecipitated with the anti-RasGAP antibody. IP, immunoprecipitation. compared with G 1 /S transition, whereas RasGAP is similarly expressed in G 1 /S and G 2 /M transitions ( Fig 4A) . As the Ras-GAP/HsAIRK-1 interaction could not be observed by immunoprecipitation with the anti-Aurora immune serum, it was analyzed during the cell cycle using a RasGAP pull-down assay (Fig. 4A) . Under these conditions, RasGAP precipitation is observed and reproducible. The RasGAP/HsAIRK-1 interaction increases in G 2 /M transition compared with G 1 /S transition, and this increase correlates with the cell cycle-dependent expression of HsHAIRK-1 protein.
Otherwise yeast two-hybrid and pull-down assays showed that survivin, a 16-kDa protein, interacts with HsAIRK-2 (24). To determine whether RasGAP forms a complex with these proteins, we studied the capacity of survivin to precipitate with RasGAP. As expected, survivin co-immunoprecipitated with HsAIRK-1 and HsAIRK-2 when they were expressed as FLAG fusion proteins in COS cells (Fig. 4B) . HsAIRK and survivin proteins are mainly expressed during the G 2 /M transition and during mitosis (22, 27) . Thus, we analyzed the co-immunoprecipitation of RasGAP and survivin in G 2 /M nocodazole-synchronized HeLa cells. In these conditions, survivin was co-immunoprecipitated with an antibody directed against RasGAP (Fig.  4C) . Conversely RasGAP co-immunoprecipitated with an antibody directed against survivin (Fig. 4C) . These results show that the existence of a ternary complex between the RasGAP, HsAIRK-1/HsAIRK-2, and survivin proteins. DISCUSSION We identified the mitotic "Aurora/Ipl1-related" kinases (referred to as Aurora hereafter) as specific in vivo partners of RasGAP, a protein involved both in the negative regulation of Ras and in Ras oncogenic activity (5) . This interaction involves the kinase domain of Aurora and the RasGAP SH3 domain. Aurora kinase is modulated in vivo by its interaction with RasGAP. This interaction is conserved between flies and humans. Moreover, the RasGAP/HsAIRK-1 interaction increases in G 2 /M transition compared with G 1 /S transition, and this increase correlates with the cell cycle-dependent expression of HsHAIRK-1 protein.
The members of the Aurora kinase family are required for the completion of mitotic events (centrosome separation, bipolar spindle assembly, chromosome separation, and cytokinesis) and are often overexpressed in tumor cells (25) . The interaction between RasGAP and Aurora may be involved in the regulation of cell division and therefore in tumor cell proliferation. The expression and activity of HsAIRK are cell cycle-dependent (22) . In fact, Aurora family proteins are produced during G 2 /M transition and mitosis. Their activation, deactivation, and degradation by the proteasome are regulated by phosphorylation (cAMP-dependent protein kinase) and dephosphorylation (protein phosphatase 1) processes (22, 26) . RasGAP may regulate HsAIRKs by recruiting them together with kinases and phosphatases, which are necessary for their activation or their inactivation and further degradation.
Our results also showed that RasGAP co-immunoprecipitated with survivin in G 2 /M synchronized HeLa cells. Survivin is an Aurora-binding protein from the inhibitory apoptotic protein family (24) . Survivin is a bifunctional protein that suppresses apoptosis, regulates cell division, and is overexpressed in tumor cells (27) . Survivin, a 16-kDa protein, could be the unknown p14 protein that co-precipitates with RasGAP SH3 domain in glutathione S-transferase pull-down assays (18) . RasGAP can generate anti-apoptotic signals through its NH 2 -terminal region in particular by means of its SH3 domain (13, 28) . Our results suggest that survivin may be the RasGAP SH3 domain target that transduces the anti-apoptotic effect of Ras-GAP in cancer cells. This effect may be transmitted or modulated via Aurora. The phosphorylation of survivin is crucial for its ability to direct cells toward division or death by apoptosis particularly in association with caspase-9 (29). The question remains as to whether survivin directly binds and inhibits caspase-9. We suggest that RasGAP and Aurora proteins are involved in the recruitment of survivin to p34 cdc2 , a kinase known to regulate survivin function (29) . This hypothesis is in accordance with the finding that RasGAP is a caspase-3 and -9 substrate and the finding that an NH 2 -terminal-generated fragment, including the SH3 domain, is involved in anti-apoptotic signaling (28) .
Finally RasGAP was shown to be involved in the maturation of Xenopus oocytes at the G 2 /M transition. The microinjection of an antibody directed against the RasGAP SH3 domain inhibits the maturation of Xenopus oocytes by preventing the activation of the maturation-promoting factor complex (cyclin B-p34 cdc2 ) by activated Ras (30) . The anti-RasGAP SH3 antibody also induces an apoptotic response when injected into tumor cells (13) . On the one hand, survivin is required for mitosis execution and is thought to be involved in the targeting   FIG. 4 . Co-precipitation of RasGAP, HsAIRK-1/HsAIRK-2, and survivin. A, HsAIRK-1 co-precipitates with RasGAP. HeLa cells were synchronized in G 1 /S or G 2 /M. Cell extracts (500 g) were submitted to RasGAP pull-down assays as described under "Experimental Procedures" followed by anti-HsAIRK-1 or anti-RasGAP immunoblots (upper and lower parts, respectively). Total cell extracts were analyzed by anti-HsAIRK-1 or anti-RasGAP immunoblots (upper and lower parts, respectively). RasGAP and HsAIRK-1 were not observed in the negative control, which consisted of CNBr-activated Sepharose beads alone (data not shown). B, HsAIRK-1 and HsAIRK-2 co-immunoprecipitated with survivin protein. COS cells were transfected with the p3XFLAG vector alone (lanes Ϫ) or fused with HsAIRK-1 or HsAIRK-2 (lanes ϩ). The immunoprecipitation experiments were done using anti-survivin or anti-FLAG antibodies. The immunoblot was probed with anti-FLAG antibody. C, RasGAP and survivin proteins co-immunoprecipitated in G 2 /M synchronized HeLa cells. Immunoprecipitations were done using pAb directed against either the COOH-terminal SH2 domain of Ras-GAP or survivin. The C lane corresponds to total cell extracts as a control of survivin protein expression. The immunoblot was probed with either a mAb directed against RasGAP (upper part) or with a pAb directed against survivin (lower part). IP, immunoprecipitation; IB, immunoblot.
of HsAIRK to its correct location on mitotic chromosomes and on the mitotic spindle apparatus. Survivin is also a mitotic substrate of p34 cdc2 -cyclin B1, and its subsequent phosphorylation is crucial for the survivin-mediated regulation of apoptosis during cell division (29) . On the other hand, Prigent et al. (22) suggested that p34 cdc2 is involved in the regulation of Aurora kinases during G 2 /M. All of these data suggest the existence of a multiprotein complex involving RasGAP, Aurora, survivin, p34 cdc2 , and caspase-9 proteins. This complex is probably involved in the balance between cell progression and apooptosis at the cell cycle G 2 /M checkpoint. This is the first study to propose a new RasGAP signaling pathway involving the formation of a ternary complex between RasGAP, Aurora/HsAIRK, and survivin. The analysis of these protein interactions will further improve our understanding of their respective roles in signal transduction. Our results open the way for studies on the RasGAP-dependent biological effects involved in Ras oncogenic transformation and tumor progression. Finally our findings suggest that the interactions between these proteins may act as potential antitumor targets.
